This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Florida Research Foundation Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Terri G Edwards: Innovator in Kinase Inhibitor Compounds
Introduction
Terri G Edwards is a prominent inventor based in Gainesville, FL. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitor compounds. Her work focuses on innovative methods for treating herpesvirus infections and associated diseases.
Latest Patents
Terri G Edwards holds a patent for the "Use of ATR and Chk1 inhibitor compounds." This invention relates to kinase inhibitor compounds and methods for identifying and utilizing them. The patent further encompasses pharmaceutical compositions and methods aimed at treating or preventing herpesvirus infections and herpesvirus-associated diseases and disorders. She has 1 patent to her name.
Career Highlights
Terri is affiliated with the University of Florida Research Foundation, Incorporated, where she continues to advance her research in the field. Her work has garnered attention for its potential impact on public health and therapeutic strategies.
Collaborations
Throughout her career, Terri has collaborated with notable colleagues, including Christopher R Fisher and David Clair Bloom. These partnerships have enriched her research and contributed to the development of innovative solutions in her field.
Conclusion
Terri G Edwards exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to kinase inhibitor compounds are paving the way for new treatments for herpesvirus infections.